AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Onconetix, Inc. Director's Dealing 2023

Oct 11, 2023

35411_dirs_2023-10-10_47dfca01-0364-48df-ac5f-90ee87c326d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Biotech, Inc. (BWV)
CIK: 0001782107
Period of Report: 2023-10-04

Reporting Person: Harmon Bruce (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$0.4305	2033-10-04	Common Stock (177442)		Direct

Footnotes

F1: The option vests in quarterly increments over a period of three years from October 4, 2023, subject to Mr. Harmon's continued employment by the company on the applicable vesting date.